Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Studies that will provide new directions for epilepsy therapy, prevention, and, ultimately, a cure and that will allow applicants to collect the data necessary to support a grant application to the National Institutes of Health or a similar granting agency are encouraged.
CURE Epilepsy encourages applications from groups underrepresented in the biomedical, clinical, behavioral, and social sciences. These groups include individuals with disabilities, veterans, persons from underrepresented racial and ethnic groups and gender-diverse groups, women in biomedical-related disciplines, or any legally protected characteristic.
CURE Epilepsy’s priority research areas focus on those that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with CURE Epilepsy's mission.
Funding requests may include salary support for the Principal Investigator (PI), technical staff, supplies necessary to perform the work, animal costs, publication fees, and travel to an epilepsy-related conference if the PI is presenting his/her CURE Epilepsy-funded research.
For additional information on eligible costs, see: https://www.cureepilepsy.org/wp-content/uploads/2023/11/2024-Taking-Flight-Award-LOI-and-Full-Proposal-Guidelines_Final.pdf#page=12